News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Artimplant Year-End Report January – December 2007
February 22, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Artimplant (STO:ARTIB): * Net revenue for the fourth quarter increased to SEK 5.0 million (1.6) and for the year to SEK 16.3 million (5.5)*
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
cardiovascular disease
Novo shutters 2 more heart disease studies, indicating IL-6 is ‘invalid target’
September 8, 2026
·
2 min read
·
Gabrielle Masson
Funding
Moonwalk pulls in $70M to take fat-targeting RNAi obesity candidate to clinic
September 8, 2026
·
2 min read
·
Michael Gibney
Funding
BrainChild Bio targets deadly pediatric brain cancer with $116M series A
September 8, 2026
·
2 min read
·
Tristan Manalac
Insights
Can Benelux turn scientific strength into larger biotech scale?
September 8, 2026
·
4 min read
·
Jennifer C. Smith-Parker